Neogenomics (NEO) Receivables - Other (2017 - 2024)
Historic Receivables - Other for Neogenomics (NEO) over the last 8 years, with Q4 2024 value amounting to $100000.0.
- Neogenomics' Receivables - Other rose 17027.03% to $100000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $100000.0, marking a year-over-year increase of 17027.03%. This contributed to the annual value of $100000.0 for FY2024, which is 17027.03% up from last year.
- Latest data reveals that Neogenomics reported Receivables - Other of $100000.0 as of Q4 2024, which was up 17027.03% from $236000.0 recorded in Q1 2024.
- Neogenomics' Receivables - Other's 5-year high stood at $2.9 million during Q3 2022, with a 5-year trough of $37000.0 in Q4 2023.
- Its 5-year average for Receivables - Other is $1.5 million, with a median of $1.9 million in 2020.
- As far as peak fluctuations go, Neogenomics' Receivables - Other crashed by 9808.19% in 2023, and later surged by 17027.03% in 2024.
- Neogenomics' Receivables - Other (Quarter) stood at $1.9 million in 2020, then rose by 2.12% to $2.0 million in 2021, then decreased by 2.28% to $1.9 million in 2022, then crashed by 98.08% to $37000.0 in 2023, then skyrocketed by 170.27% to $100000.0 in 2024.
- Its Receivables - Other stands at $100000.0 for Q4 2024, versus $236000.0 for Q1 2024 and $37000.0 for Q4 2023.